MedTrace Logo

Impact of Osteopathic Manipulative Therapy on Hip Range of Motion

NCT06644989 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-10-24

No results posted yet for this study

Summary

One way for runners to improve their performance and remain injury free is to preserve and improve joint mobility, especially at the hips. The femoroacetabular joints are a pivotal part of the running gait allowing the athlete to fully extend their leg to generate sufficient force in each stride. Improving hip range of motion can help reduce or prevent groin pain, make the runner more comfortable while running, improve running longevity, and prevent injuries. Thus, it is clear that a runner's commitment to improving the range of motion of their hips is crucial for both the enhancement of their performance and prevention of injury. Researchers assessed how the hip, and its biomechanics, can be impacted by Osteopathic medical treatment.

The primary research question investigated is how Spencer Technique for the hip impacts femoral acetabular active range of motion (AROM) in flexion, extension, abduction, adduction, internal rotation, and external rotation in those training 4 weeks for a 5K race. This study investigated the effect that 4 weeks of twice weekly, bilateral, Spencer Technique treatment had on femoroacetabular range of motion. During this 4-week period participant exercise and stretching habits in preparation for the 5k race were recorded.

Conditions

  • Runners

Interventions

PROCEDURE

Spencer Technique

Spencer technique on the hip

OTHER

Sham (No Treatment)

Spencer technique position but no pressure

Sponsors & Collaborators

  • Lake Erie College of Osteopathic Medicine (LECOM)

    collaborator UNKNOWN

  • Lake Erie College of Osteopathic Medicine

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-02-29
Completion
2024-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06644989 on ClinicalTrials.gov